Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ioflupane 123I

Drug Profile

Ioflupane 123I

Alternative Names: DaTSCAN; DaTscan; Ioflupane (123I); Radio-labelled ioflupane; β-CIT-FP

Latest Information Update: 04 Sep 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GE Healthcare
  • Class Diagnostic agents; Nortropanes; Small molecules
  • Mechanism of Action Single-photon emission-computed tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Dementia; Lewy body disease; Multiple system atrophy; Parkinsonian disorders; Progressive supranuclear palsy

Most Recent Events

  • 10 Dec 2019 GE Healthcare plans a phase III trial for Parkinsonian disorders (Diagnosis) in China (GE-001-024; CTR20191992; NCT04193527)
  • 24 Jun 2018 Biomarkers information updated
  • 27 Apr 2015 Ioflupane 123I licensed to Nihon Medi-Physics in Japan before April 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top